Atenolol and cardiovascular risk: an issue close to the heart

被引：25

作者：

Wilkinson, IB

McEniery, CM

Cockcroft, JR ^{[1
]}

机构：

[1] Wales Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, Wales

[2] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England

来源：

LANCET | 2006年 / 367卷 / 9511期

关键词：

D O I：

10.1016/S0140-6736(06)68238-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：627 / 629

页数：3

共 16 条

[1]

*CAFE INV, 2006, CIRCULATION

[2] Atenolol in hypertension: is it a wise choice? [J].

Carlberg, B ;

Samuelsson, O ;

Lindholm, LJ .

LANCET, 2004, 364 (9446) :1684-1689

[3]

Cockcroft JR, 2002, LANCET, V359, P2202, DOI 10.1016/S0140-6736(02)09075-X

[4] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[5] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].

Dahlöf, B ;

Sever, PS ;

Poulter, NR ;

Wedel, H ;

Beevers, DG ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2005, 366 (9489) :895-906

[6] Atenolol and eprosartan: Differential effects on central blood pressure and aortic pulse wave velocity [J].

Dhakam, Z ;

McEniery, CM ;

Yasmin ;

Cockcroft, JR ;

Brown, MJ ;

Wilkinson, IB .

AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (02) :214-219

[7]

Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981

[8] ARTERIAL DILATION AND REDUCED WAVE REFLECTION - BENEFIT OF DILEVALOL IN HYPERTENSION [J].

KELLY, R ;

DALEY, J ;

AVOLIO, A ;

OROURKE, M .

HYPERTENSION, 1989, 14 (01) :14-21

[9] Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis [J].

Lindholm, LH ;

Carlberg, B ;

Samuelsson, O .

LANCET, 2005, 366 (9496) :1545-1553

[10] Effect of different antihypertensive drug classes on central aortic pressure [J].

Morgan, T ;

Lauri, L ;

Bertram, D ;

Anderson, A .

AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (02) :118-123

← 1 2 →